Edition:
United States

McKesson Corp (MCK)

MCK on New York Consolidated

138.29USD
28 Apr 2017
Change (% chg)

$-0.50 (-0.36%)
Prev Close
$138.79
Open
$138.70
Day's High
$138.99
Day's Low
$137.69
Volume
1,523,399
Avg. Vol
1,797,158
52-wk High
$199.43
52-wk Low
$114.53

MCK

Chart for MCK

About

McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty... (more)

Overall

Beta: 1.10
Market Cap(Mil.): $29,430.77
Shares Outstanding(Mil.): 212.05
Dividend: 0.28
Yield (%): 0.81

Financials

  MCK Industry Sector
P/E (TTM): 15.32 20.13 41.34
EPS (TTM): 9.06 -- --
ROI: 11.30 9.13 62.37
ROE: 24.76 10.70 73.84

BRIEF-Mckesson anticipates recording pre-tax gain of about $2.9 to $3.5 bln in Q4

* As a result of net gain from transaction, co to add about $10.70-$12.35 in Q4 GAAP earnings per share from continuing operations

Mar 02 2017

Fitch Rates McKesson's EUR and GBP Notes 'BBB+'; Outlook Stable

(The following statement was released by the rating agency) NEW YORK, February 13 (Fitch) Fitch Ratings has assigned 'BBB+' ratings to the EUR and GBP denominated senior unsecured notes issued by McKesson Corp. (NYSE: MCK). A full list of ratings follows at the end of the release. KEY RATING DRIVERS Stable Operations, Low Margins The credit profiles of MCK and its peers benefit from stable operating profiles and consistent cash generation. Steady pharmaceutical demand, an oligopolistic drug

Feb 13 2017

Thoma Bravo explores sale of Global Health Exchange-sources

Buyout firm Thoma Bravo LLC is exploring a sale of Global Health Exchange (GHX), a software company that helps track medical and surgical supplies that could be worth as much as $1.3 billion, including debt, according to people familiar with the matter.

Jan 31 2017

Thoma Bravo explores sale of Global Health Exchange-sources

Jan 31 Buyout firm Thoma Bravo LLC is exploring a sale of Global Health Exchange (GHX), a software company that helps track medical and surgical supplies that could be worth as much as $1.3 billion, including debt, according to people familiar with the matter.

Jan 31 2017

BRIEF-Mckesson announces purchase of CoverMyMeds

* McKesson announces purchase of CoverMyMeds, a Francisco Partners portfolio company

Jan 26 2017

McKesson's revenue misses as pace of drug price hikes slow

Drug distributor McKesson Corp's quarterly revenue missed estimates due to slowing pace of branded drug price increases amid rising concerns over soaring prices of medicines.

Jan 25 2017

UPDATE 2-McKesson's revenue misses as pace of drug price hikes slow

Jan 25 Drug distributor McKesson Corp's quarterly revenue missed estimates due to slowing pace of branded drug price increases amid rising concerns over soaring prices of medicines.

Jan 25 2017

BRIEF-McKesson to acquire CoverMyMeds for about $1.1 bln

* Q3 gaap earnings per share $2.86 from continuing operations

Jan 25 2017

McKesson to buy CoverMyMeds for $1.1 bln

Jan 25 Drug wholesaler McKesson Corp said it would buy privately held CoverMyMeds for about $1.1 billion to strengthen its technology offerings to pharmaceutical manufacturers, clinicians and health insurers.

Jan 25 2017

McKesson in record $150 mln U.S. settlement over suspicious drug orders

McKesson Corp, one of the largest U.S. distributors of pharmaceutical drugs, will pay a record $150 million to resolve a U.S. investigation into whether it failed to report suspicious orders of addictive painkillers.

Jan 17 2017

More From Around the Web

Earnings vs. Estimates